Table of contents
Bone marrow - neoplastic myeloid
General:books
transient abnormal myelopoiesis associated with Down syndrome
WHO classification - AML
Recurrent genetic abnormalities:AML with BCR-ABL1 (pending)
AML with biallelic mutation of CEBPA (pending)
AML with mutated NPM1
AML with mutated RUNX1
AML with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2)
AML with inv(16)(p13.1;q22) or t(16;16)(p13.1;q22)
AML (megakaryoblastic) with t(1;22)(p13.3;q13.1)
AML with t(6;9)(p23;q34)
AML with t(8;21)(q22;q22)
AML with t(9;11)(p22;q23)
APL with PML-RARA
AML not otherwise specified:AML with minimal differentiation (FAB AML M0)
AML without maturation (FAB AML M1)
AML with maturation (FAB AML M2)
AMML (FAB AML M4)
AML M5
M5a
M5b
AML M6
AMKL M7
acute basophilic leukemia
AML with pseudo-Chediak-Higashi anomaly
AML hypocellular
Other AML entities defined by the WHO:myeloid leukemia associated with Down syndrome
AML therapy related
AML with myelodysplasia related changes
myeloid sarcoma
acute panmyelosis with myelofibrosis
Other AML of clinical relevance:AML with FLT3
Myelodysplastic syndromes (MDS):WHO classification - MDS
MDS prognostic scoring
MDS in childhood
refractory cytopenia of childhood (pending)
MDS with single lineage dysplasia
MDS with ring sideroblasts
MDS with multilineage dysplasia
MDS with excess blasts
isolated del(5q)
MDS unclassifiable
Myeloproliferative neoplasms (MPN):WHO classification - MPN
chronic eosinophilic leukemia
chronic myeloid leukemia (CML)
chronic neutrophilic leukemia
essential thrombocythemia
polycythemia vera
primary myelofibrosis
MPN unclassifiable
Mast cell neoplasms: systemic mastocytosis
MDS / MPN: WHO classification - MDS / MPN
atypical chronic myeloid leukemia
chronic myelomonocytic leukemia
juvenile myelomonocytic leukemia
MDS / MPN - unclassifiable
MDS / MPN with ring sideroblasts and thrombocytosis
Myeloid / lymphoid neoplasms with eosinophilia and gene rearrangement: PDGFRA rearrangement
PDGFRB rearrangement
FGFR1 rearrangement
PCM1-JAK2
Myeloid neoplasms with germline predisposition without a pre-existing disorder or organ dysfunction:AML with germline CEBPA mutation (pending)
with DDX41 mutation (pending)
Myeloid neoplasms with germline predisposition and pre-existing platelet disorders: with RUNX1 mutation (pending)
with ANKRD26 mutation (pending)
with ETV6 mutation (pending)
Myeloid neoplasms with germline predisposition and other organ dysfunction: with bone marrow failure (pending)
with GATA2 mutation
with telomere biology disorders (pending)
with Down syndrome (pending)
Bone marrow - plasma cell and lymphoid neoplasms
Plasma cell neoplasms:heavy chain disease
MGUS-IgM
MGUS-non IgM
non secretory myeloma (pending)
plasma cell myeloma (multiple myeloma)
plasma cell leukemia (pending)
plasmacytoma
POEMS syndrome (osteosclerotic myeloma)
TEMPI syndrome (pending)
Other:acute lymphoblastic leukemia / lymphoma
cryoglobulinemia
monoclonal immunoglobulin deposition diseases (pending)
primary amyloidosis
B lymphoblastic leukemia/lymphoma with recurrent genetic abnormalities:t(1;19)(q23;p13.3)
t(5;14)(q31;q32)
t(9;22)(q34;q11)
t(12;21)(p13;q22)
t(v;11q23)
BCR-ABL1-like
therapy-related B-ALL (pending)
with hyperdiploidy
with hypodiploidy
with iAMP21 (pending)
NK and T cell precursor lymphoid neoplasms:T lymphoblastic lymphoma / leukemia
early T cell precursor lymphoblastic leukemia (pending)
NK lymphoblastic leukemia/lymphoma (pending)
Acute leukemia of ambiguous lineage: mixed phenotype
ambiguous lineage NOS
acute undifferentiated leukemia (pending)
Disorders from other chapters:
B lymphoblastic leukemia / lymphoma
crystal storing histiocytosis
cutaneous mastocytosis
heavy chain deposition disease
light chain deposition disease
Bone marrow neoplastic stains: CD3 CD34 CD68 CD117 E-cadherin MPO PAX5 TdT
Bone marrow neoplastic stains: CD3 CD34 CD68 CD117 E-cadherin MPO PAX5 TdT
Index (Alphabetical table of contents)
A-E:acute basophilic leukemia
acute lymphoblastic leukemia / lymphoma
acute panmyelosis with myelofibrosis
acute undifferentiated leukemia (pending)
ambiguous lineage NOS
AMKL M7
AML (megakaryoblastic) with t(1;22)(p13.3;q13.1)
AML hypocellular
AML M5
AML M6
AML therapy related
AML with BCR-ABL1 (pending)
AML with biallelic mutation of CEBPA (pending)
AML with FLT3
AML with germline CEBPA mutation (pending)
AML with inv(16)(p13.1;q22) or t(16;16)(p13.1;q22)
AML with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2)
AML with maturation (FAB AML M2)
AML with minimal differentiation (FAB AML M0)
AML with mutated NPM1
AML with mutated RUNX1
AML with myelodysplasia related changes
AML with pseudo-Chediak-Higashi anomaly
AML with t(6;9)(p23;q34)
AML with t(8;21)(q22;q22)
AML with t(9;11)(p22;q23)
AML without maturation (FAB AML M1)
AMML (FAB AML M4)
APL with PML-RARA
atypical chronic myeloid leukemia
BCR-ABL1-like
blastic plasmacytoid dendritic cell neoplasm
chronic eosinophilic leukemia
chronic myeloid leukemia (CML)
chronic myelomonocytic leukemia
chronic neutrophilic leukemia
cryoglobulinemia
early T cell precursor lymphoblastic leukemia (pending)
essential thrombocythemia
F-N:FGFR1 rearrangement
heavy chain disease
hypereosinophilic syndrome
isolated del(5q)
juvenile myelomonocytic leukemia
M5a
M5b
MDS / MPN - unclassifiable
MDS / MPN with ring sideroblasts and thrombocytosis
MDS in childhood
MDS prognostic scoring
MDS unclassifiable
MDS with excess blasts
MDS with multilineage dysplasia
MDS with ring sideroblasts
MDS with single lineage dysplasia
MGUS-IgM
MGUS-non IgM
mixed phenotype
monoclonal immunoglobulin deposition diseases (pending)
MPN unclassifiable
myeloid leukemia associated with Down syndrome
myeloid sarcoma
NK lymphoblastic leukemia/lymphoma (pending)
non secretory myeloma (pending)
O-Z:PCM1-JAK2
PDGFRA rearrangement
PDGFRB rearrangement
plasma cell leukemia (pending)
plasma cell myeloma (multiple myeloma)
plasmacytoma
POEMS syndrome (osteosclerotic myeloma)
polycythemia vera
primary amyloidosis
primary myelofibrosis
refractory cytopenia of childhood (pending)
systemic mastocytosis
T lymphoblastic lymphoma / leukemia
t(12;21)(p13;q22)
t(1;19)(q23;p13.3)
t(5;14)(q31;q32)
t(9;22)(q34;q11)
t(v;11q23)
TEMPI syndrome (pending)
therapy-related B-ALL (pending)
transient abnormal myelopoiesis associated with Down syndrome
WHO classification - AML
WHO classification - MDS
WHO classification - MDS / MPN
WHO classification - MPN
with ANKRD26 mutation (pending)
with DDX41 mutation (pending)
with ETV6 mutation (pending)
with RUNX1 mutation (pending)
with bone marrow failure (pending)
with Down syndrome (pending)
with GATA2 mutation
with hyperdiploidy
with hypodiploidy
with iAMP21 (pending)
with telomere biology disorders (pending)
Bone marrow neoplastic books
Cherry: 2021
Hsi: 2017
IARC: 2017
Jaffe: 2016
Kantarjian: 2016
Lanzkowsky: 2016
Naeim: 2018
Find related Pathology books: hematopathology, oncology, pediatric
